Michael Ryskin
Stock Analyst at B of A Securities
(1.56)
# 3,410
Out of 5,072 analysts
38
Total ratings
54.17%
Success rate
-0.16%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Buy | $110 → $99 | $104.41 | -5.18% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $77.93 | -10.18% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $752.88 | -36.91% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.62 | +120.99% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $147.19 | +39.96% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $108.42 | -63.11% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $2.31 | +311.26% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $9.16 | +162.01% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $11.73 | +104.60% | 2 | Jul 31, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $180 | $128.18 | +40.43% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.63 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $80 → $52 | $17.56 | +196.13% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.17 | +215.46% | 2 | Nov 10, 2021 |
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $104.41
Upside: -5.18%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $77.93
Upside: -10.18%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $752.88
Upside: -36.91%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.62
Upside: +120.99%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $147.19
Upside: +39.96%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $108.42
Upside: -63.11%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $2.31
Upside: +311.26%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $9.16
Upside: +162.01%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.73
Upside: +104.60%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $128.18
Upside: +40.43%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.63
Upside: -
Nov 11, 2021
Downgrades: Neutral
Price Target: $80 → $52
Current: $17.56
Upside: +196.13%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.17
Upside: +215.46%